Terpenoid ID | TKC104558 | |
Cell line | 0 | |
Protein target | 13 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 22 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC104558 | HepG2 | 14125.0 | nM | Potency | C3728 | Orphanet_449 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC104558 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 16360 | nM | Potency |
TKC104558 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 29093 | nM | Potency |
TKC104558 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 22387 | nM | Potency |
TKC104558 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 11220 | nM | Potency |
TKC104558 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 11220 | nM | Potency |
TKC104558 | Q77YF9 | Protein Vpr | vpr | 50119 | nM | Potency |
TKC104558 | Q99700 | Ataxin-2 | ATXN2 | 39811 | nM | Potency |
TKC104558 | O75164 | Lysine-specific demethylase 4A | KDM4A | 44668 | nM | Potency |
TKC104558 | O75496 | Geminin | GMNN | 29093 | nM | Potency |
TKC104558 | P37840 | Alpha-synuclein | SNCA | 28184 | nM | Potency |
TKC104558 | P39748 | Flap endonuclease 1 | FEN1 | 35481 | nM | Potency |
TKC104558 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 35481 | nM | Potency |
TKC104558 | P83916 | Chromobox protein homolog 1 | CBX1 | 22387 | nM | Potency |
TKC104558 | P61088 | Ubiquitin-conjugating enzyme E2 N | UBE2N | >20000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
P37840 | SYUA_HUMAN | Parkinsonism [ICD-11: 8A00] |
P37840 | SYUA_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P37840 | SYUA_HUMAN | Autonomic nervous system disorder [ICD-11: 8D87] |
Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |